Germany· DE-A57-d7668b8445f0bd2a
Digitoxin-Philo
A digitoxin product containing digitoxin, registered in Germany by Mibe Gmbh Arzneimittel. The same ATC class is registered in 3 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Digitoxin is registered in 3 of 19 countries.
Countries holding a registration under ATC C01AA04 (digitoxin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 1 of them publish a price we can compare per daily dose
Digitoxin · ATC C01AA04
3 / 19 countries
- Finlandprice
- Germany
- United Kingdom
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Digitoxin
- Manufacturer
- Mibe Gmbh Arzneimittel
- Country
- Germany (DE)
- ATC code
- C01AA04
- ATC class
- Digitoxin
- Defined daily dose
- 0.1 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
125 interactions on record for digitoxin.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Digitoxin · interactions on record
125 records
- 14 severe
- 95 moderate
- 16 minor
Most severe, free to view
- DolasetronA04AA04severe
- Calcium gluconateA12AA03severe
- Calcium chlorideA12AA07severe
- Calcium glucoheptonateA12AA10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C01AA04
Digitoxin, as other registers publish it.
- GermanyDigimerckMerck Healthcare Germany Gmbh
- GermanyDigimerckMerck Healthcare Germany Gmbh
- GermanyDigimerck MinorMerck Healthcare Germany Gmbh
- GermanyDigimerck PicoMerck Healthcare Germany Gmbh
- FinlandDigitoxinSchering Oy
- FinlandDigitoxinSTAR
- United KingdomDigitoxin 100microgram tabletsFocus Pharmaceuticals Ltd
- United KingdomDigitoxin 100microgram tabletsAlliance Healthcare (Distribution) Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e4cd3981-2fad-44a1-94dc-511191a9e5e0 GET /v1/drugs/e4cd3981-2fad-44a1-94dc-511191a9e5e0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Digitoxin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about digitoxin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.